ERCC3 and neoplasm: IHC analysis indicated an obviously ERCC3 negative in the tumor tissues of the patient with p.Y116X mutation, while in tissues of patients with variants of uncertain significance, mild or moderate staining nucleus in >80% of cells was found (Supplementary Figures 2 and 3).